Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm

被引：4
|
作者：
Castiglione, Melissa [1 ]
Zhang, Haotian [2 ]
Kaushansky, Kenneth [3 ]
Zhan, Huichun [1 ,4 ]
机构：
[1] Stony Brook Sch Med, Dept Med, HSC T15,Room 053, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Grad Program Mol & Cellular, Stony Brook, NY 11794 USA
[3] Stony Brook Sch Med, Hlth Sci, Stony Brook, NY USA
[4] Northport VA Med Ctr, Med Serv, Northport, NY 11768 USA
来源：
EXPERIMENTAL HEMATOLOGY | 2021年 / 100卷
关键词：
HEMATOPOIETIC STEM; ENDOTHELIAL-CELLS; CLONAL HEMATOPOIESIS; SOMATIC MUTATIONS; PROGENITOR CELLS; TRANSPLANTATION; MYELOFIBROSIS; EXPANSION; CANCER; CONTRIBUTES;
D O I：
10.1016/j.exphem.2021.06.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：52 / 62
页数：11
相关论文
共 50 条
  • [11] Imbalance between Tolerant and Cytotoxic Functional Subsets of NK Cells in a JAK2V617F Myeloproliferative Neoplasm Model
    Bianco, Thiago Mantello
    Arantes, Adriana Queiroz
    Lopes, Izabela Aparecida
    Scheucher, Priscila Santos
    Silva, Cleide Araujo
    Mullally, Ann
    Kobayashi, Susumu S.
    Rego, Eduardo Magalhaes
    Figueiredo-Pontes, Lorena Lobo
    BLOOD, 2017, 130
  • [12] Correlative study between the JAK2V617F mutation and thrombosis in patients with myeloproliferative neoplasm
    Li, Z. C.
    Fu, H. J.
    Wang, Z. M.
    Yang, S.
    Xu, H. Z.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (03):
  • [13] Discussion of the correlation between JAK2V617f mutation and thromboembolism in myeloproliferative neoplasm patients
    Xia, L.
    Wu, J-S
    Ding, K-Y
    Zeng, Q-S
    Cai, X-Y
    Zhu, W-B
    Wu, L-L
    Liu, X.
    Yang, H-Z
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 635 - 636
  • [14] Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera
    Mullally, Ann
    Bruedigam, Claudia
    Poveromo, Luke
    Heidel, Florian H.
    Purdon, Amy
    Vu, Therese
    Austin, Rebecca
    Heckl, Dirk
    Breyfogle, Lawrence J.
    Kuhn, Catherine Paine
    Kalaitzidis, Demetrios
    Armstrong, Scott A.
    Williams, David A.
    Hill, Geoff R.
    Ebert, Benjamin L.
    Lane, Steven W.
    BLOOD, 2013, 121 (18) : 3692 - 3702
  • [15] Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2V617F does not mean absence of myeloproliferative neoplasm
    Peyro-Saint-Paul, Helene
    Hermitte, Fabienne
    BLOOD, 2010, 116 (11) : 1994 - 1995
  • [16] Transgenic Expression of Wild Type JAK2 Suppresses Myeloproliferative Disorder Phenotypes Induced by Mutant JAK2V617F in Mice
    Xing, Shu
    Zhao, Wanming
    Ho, Wanting Tina
    Zhao, Zhizhuang Joe
    BLOOD, 2008, 112 (11) : 73 - 73
  • [17] A Murine Model with JAK2V617F Expression in Both Hematopoietic Cells and Vascular Endothelial Cells Recapitulates the Key Features of Human Myeloproliferative Neoplasm
    Zhang, Haotian
    Yeware, Amar
    Lee, Sandy
    Zhan, Huichun
    BLOOD, 2021, 138
  • [18] A Murine Model With JAK2V617F Expression in Both Hematopoietic Cells and Vascular Endothelial Cells Recapitulates the Key Features of Human Myeloproliferative Neoplasm
    Zhang, Haotian
    Yeware, Amar
    Lee, Sandy
    Zhan, Huichun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [19] Prevalence of JAK2V617F, CALR in Philadelphia Positive and Negative Myeloproliferative Neoplasm
    Abedi, Elham
    Karimi, Mehran
    Cohan, Nader
    Haghpanah, Sezaneh
    Yaghobi, Ramin
    Azarpira, Negar
    Moghadam, Mohamad
    Bayat, Elahe
    Farokhian, Farnoush
    Mohammadi, Hamid
    Lak, Elahe Razmara
    Golafshan, Habib Allah
    Ramzi, Mani
    GALEN MEDICAL JOURNAL, 2021, 10
  • [20] A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
    C Marty
    C Lacout
    N Droin
    J-P Le Couédic
    V Ribrag
    E Solary
    W Vainchenker
    J-L Villeval
    I Plo
    Leukemia, 2013, 27 : 2187 - 2195
12345